Returning Subscriber?
Not a Subscriber to Litigation Pathfinder?
Get the full text of this legal issue, including links to cited primary law, along with unlimited access 1,000’s of other legal issues…and more!
Area of Law: | Healthcare & Pharmaceutical Law Compliance |
Keywords: | Pseudoephedrine; Regulated transactions; Suspicious transaction reporting requirement |
Jurisdiction: | Federal |
Cited Cases: | None |
Cited Statutes: | 21 U.S.C. § 830(b)(1)(A); 21 U.S.C. § 830 (a)(3); 21 C.F.R. § 1310.04 (f); 21 U.S.C. § 802(39)(A) |
Date: | 12/01/2001 |
If a transaction is a "regulated transaction " then it is subject to the "suspicious transaction" reporting requirements of 21 U.S.C. § 830(b)(1)(A) and purchase identification requirement of 21 U.S.C. § 830 (a)(3). The Attorney General has established a "threshold amount" for pseudoephedrine at one kilogram per customer per month. 21 C.F.R. § 1310.04 (f). The only transactions that are regulated transactions are those made at or in excess of that cumulative monthly amount. See 21 U.S.C. § 802(39)(A).
[…]
Subscribe to Litigation Pathfinder
To get the full-text of this Legal Memorandum ... and more!
(Month-to-month and annual subscriptions available)
Get the full text of this legal issue, including links to cited primary law, along with unlimited access 1,000’s of other legal issues…and more!